Antiretroviral therapy for children in the routine setting in Malawi

    Insights

    Malawi

    Area of Science:

    • Pediatrics
    • Infectious Diseases
    • Public Health

    Background:

    • Malawi is expanding access to antiretroviral therapy (ART) for individuals living with HIV.
    • A fixed-dose combination of stavudine, lamivudine, and nevirapine (Triomune) is utilized as the primary treatment regimen.
    • Pediatric dosing involves splitting tablets based on body weight.

    Purpose of the Study:

    • To evaluate the outcomes of antiretroviral therapy (ART) in children compared to adults in Malawi.
    • To assess the effectiveness and safety of a fixed-dose combination regimen in pediatric HIV treatment.
    • To inform national programs on the importance of pediatric ART and outcome monitoring.

    Main Methods:

    • Analysis of a national cohort of HIV-infected patients initiated on ART between July-September 2005 and January-March 2005.
    • Inclusion of a subset of 935 children with detailed age and gender distribution.
    • Cohort outcomes were assessed at six and twelve months, censored on March 31, 2006.

    Main Results:

    • A total of 46,702 patients initiated ART, with 5.8% being children under 15.
    • Six-month outcomes showed significantly higher survival rates and lower mortality/default rates in children compared to adults.
    • Twelve-month outcomes also demonstrated significantly better survival rates for children versus adults.

    Conclusions:

    • Pediatric antiretroviral therapy (ART) in Malawi demonstrates favorable outcomes compared to adults.
    • The study supports increased investment in pediatric HIV treatment programs.
    • Continuous monitoring of pediatric ART treatment outcomes is crucial for program improvement.

    Related Concept Videos

    Retrovirus Life Cycles01:10

    Retrovirus Life Cycles

    Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    Respiratory Syncytial Virus Disease01:29

    Respiratory Syncytial Virus Disease

    Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
    Retroviruses02:33

    Retroviruses

    Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
    Antiviral Nucleoside Inhibitors01:22

    Antiviral Nucleoside Inhibitors

    Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
    Drug Dosing: Infants and Children01:29

    Drug Dosing: Infants and Children

    Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...